Akron to collaborate with Vor Bio on nucleases

By The Science Advisory Board staff writers

March 24, 2022 -- Akron BioProducts and Vor Bio have announced an agreement to develop and manufacture current good manufacturing practice nucleases.

The collaboration strengthens Akron's portfolio of off-the-shelf gene editing technologies and broadens Vor Bio's collection of nucleases to engineer gene modified cell therapies, the companies said.

The collaboration also will focus on developing and manufacturing starting materials needed to advance potential treatments for blood cancers, the companies said.


Copyright © 2022 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.